Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Materials in this section
Hepatitis C and TB Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
A patent landscape, released by TAG, investigates potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines. More
Have A Heart, Save My Liver! Which Countries Restrict Treatment?
A fact sheet, developed by the hepCoalition, provides in-country data about HCV treatment rationing through different forms of restrictions. More
Have a Heart, Save My Liver! Where is the Cure Registered?
A fact sheet, developed by the hepCoalition, provides in-country data to understand where the branded and generic versions of the HCV cure have been registered and to inform advocacy efforts. More
PEPFAR Watch!—Resource Tools for Funding Advocacy
PEPFAR Watch tracks the specific language in the Country Operational Plans, and activists prepare recommendations and demands to improve the policy guidance and inform service delivery. More
Activist Guide to Hepatitis C Virus Diagnostics
A new Activist Guide, developed by TAG, provides a deeper focus on diagnosis with updated information about the steps and different technologies involved in diagnosing a person with HCV. More
Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report
GHRN, in partnership with FIND, TAG, and the Georgia CAB, convened an advocacy workshop to focus on strategies to overcome barriers to diagnostics in the national hepatitis C elimination plan. More
Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report
Positive Malaysian Treatment Access and Advocacy Group, in partnership with FIND and TAG, convened the first advocacy workshop on hepatitis C diagnostics. More
Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV
A Training Manual, developed by Treatment Action Group, supports community advocacy efforts for access to prevention, treatment, and care for HCV. More
Forging a Path to HCV Elimination: Simpler Tests and Affordable Generics
Report of the World Community Advisory Board on HCV Generics and Diagnostics, 18-20 July 2017, Bangkok, Thailand
Treatment activists met with generics and diagnostics companies to present demands and obtain strategic information from companies on critical access issues in low- and middle-income countries. More
Trainings
Hepatitis C and harm reduction for people who use drugs
In 2016, Médecins du Monde organized a series of trainings on hepatitis C intended for its Harm Reduction international teams and partners with a focus on people who use drugs. More
